Podchaser Logo
Home
For Pharmacists: Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma

For Pharmacists: Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma

Released Wednesday, 17th April 2024
Good episode? Give it some love!
For Pharmacists: Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma

For Pharmacists: Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma

For Pharmacists: Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma

For Pharmacists: Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma

Wednesday, 17th April 2024
Good episode? Give it some love!
Rate Episode

Did you know that HER2-targeted therapy is an established treatment option for patients with HER2-positive metastatic gastric/gastroesophageal junction (GEJ) cancer?

Credit available for this activity expires: 4/16/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000688?ecd=bdc_podcast_libsyn_mscpedu

Show More
Rate

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more

Episode Tags

Do you host or manage this podcast?
Claim and edit this page to your liking.
,

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features